- - - - -
View Replies »
|Small Cap Equities Conference June 2 Features Advance Viral, Cenuco|
|Thursday , March 25, 2004 02:08 ET|
|Mar 25, 2004 (financialwire.net via COMTEX) -- (FinancialWire) The
Investrend / Symposium "Small Cap Equities Conference" has been
scheduled at the Roosevelt Hotel in New York City for June 2.
Companies signed early for presentations include Advanced Viral Research Corp. (OTCBB: ADVR), and Cenuco Inc. (OTCBB: CNUO).
ADVR's AVR118 represents a biopolymer that possesses novel immunomodulator activity. This peptide-nucleic acid, which to date has shown a very favorable safety profile, appears to stimulate the proinflammatory responses required to combat viral infections such as HIV and human papillomavirus and to dampen aberrant autoimmune-type inflammatory responses, such as occur in patients with rheumatoid arthritis. AVR118 is in clinical trials in Israel for the treatment of cachexia (body wasting) in patients with AIDS.
Cenuco's products include: MommyTrack(TM) -- a retail consumer product allowing families to see their home/children from anywhere via live streaming video on cellular phones, Pocket PCs, Intel Centrino Mobile Technology based- laptops, and Internet-connected computers; Mobile Video Monitor(TM) -- a product line allowing business owners and corporations to see any CCTV camera at any location in real-time via cellular phones, Pocket PCs, Intel Centrino mobile technology, and Internet-connected computers; and Mobile Video Transmitter(TM) for Corporations/Government/Homeland security -- a product line which allows for remote connectivity to video surveillance systems at critical infrastructure sites via live video streams onto wireless Pocket PC 2003, Intel Centrino laptops, and Internet-connected computers.
Investrend Forums partners with Symposium LLC in its Central Booking facility at http://www.investrendforums.com. Companies interested in presenting may click on http://www.investrend.com/contact.asp .
For up-to-the-minute news, features and links click on http://www.financialwire.net
FinancialWire is an independent, proprietary news service of Investrend Information, a division of Investrend Communications, Inc. It is not a press release service and receives no compensation for its news or opinions. Other divisions of Investrend, however, provide shareholder empowerment platforms such as forums, independent research and webcasting. For more information or to receive the FirstAlert daily summary of news, commentary, research reports, webcasts, events and conference calls, click on http://www.investrend.com/contact.asp
The FinancialWire NewsFeed is now available in multiple formats to your site or desktop, free. Click on: http://www.investrend.com/XmlFeeds?level=268
(C) 2004 financialwire.net, Inc. All rights reserved.
is exactly one of the next steps for ADVR
What would be better [and it will come in time if all goes well] is a headline that says "ADVR TO ATTEND ADAMS HARKNESS
BIOTECH SEMINAR AT THE
WALDORF IN NEW YORK"
step by step
4titude. June is a pretty busy month for ADVR; i.e., the ASCO abstract
presentation in NOLA on June 5-8 and now this latest Symposium on June
2. Does anyone know what type of presentation would likely take place?
Not sure exactly what a Equities Conference is all about. TIA